# Matrisome Bio, Inc.

Canonical: https://abierto.us/vendors/matrisome-bio-inc-dwr8lnqucjr8

- UEI: DWR8LNQUCJR8
- CAGE: 07E56
- Location: Cambridge, MA
- Awards in window: 1 (2 transactions), $299,496 obligated, September 11, 2025 to September 10, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $299,496

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $299,496

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91025C00039 (definitive contract): $299,496, NIH NCI. Novel Theranostic Radioligands Targeting Disease-Specific Extracellular Matrix Components Specific to Tumor and Metastatic Lesions in Patients Suffering from Hereditary Breast and Ovarian Cancer (Hboc). https://www.usaspending.gov/award/CONT_AWD_75N91025C00039_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/matrisome-bio-inc-dwr8lnqucjr8.